Changing the balance in apoptosis: key to enhance cisplatin sensitivity of testicular cancer
PhD ceremony: Mr. R. Koster, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen
Thesis: Changing the balance in apoptosis: key to enhance cisplatin sensitivity of testicular cancer
Promotor(s): prof. J.A. Gietema, prof. R.P.H. Bischoff
Faculty: Medical Sciences
Testicular cancer is considered a paradigm of curable solid tumor and is therefore a very helpful “model” to investigate and understand the molecular determinants of chemotherapy sensitivity (and resistance) of solid tumors. Knowledge about mechanisms involved in the sensitivity and resistance of testicular cancer to DNA-damaging agents might contribute to the design of new treatment strategies to overcome cisplatin resistance of refractory testicular cancers and of other types of human cancers.
| Last modified: | 13 March 2020 01.16 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.